Patients who are about to begin or who have recently begun taking any GLP-1 medication should thus have a dilated eye examination to assess risk factors for developing NAION
4 hours | Primary site of action: vascular signaling pathways, NO system | Key receptors: VEGFR2, eNOS | Research focus: gastrointestinal, tendons, inflammation | Endogenous: no (synthetic, derived from gastric juice) | Gene modulation: limited documentation TB-500 Half-life: approx
Suitable only for professional laboratory environments
No clinically useful instant result is guaranteed
Composition & Format Active peptide: Melanotan I (MT1), CAS 75921-69-6 Strength: 10 mg peptide per clear glass vial Format: White lyophilized peptide powder Kit configuration: 10 vials per kit for convenient repack or redistribution Origin: China-based factory with export experience for cosmetic peptide lines Key Features for Wholesale Buyers High-purity (99%) MT1 peptide designed for consistent cosmetic research outputs China-based factory-direct supply to support bulk and OEM/private-label projects White lyophilized powder for flexible solvent selection and protocol design Stable batch-to-batch quality with documentation (COA/HPLC data available upon request) Suitable for distributors, clinics research departments and peptide resellers seeking reliable MT1 inventory Packaging & Ordering Standard kit: 10 vials 10 mg Melanotan I (MT1) per kit Vials packed in protective plastic trays, then placed inside export-ready outer cartons Factory-direct B2B terms
